Opendata, web and dolomites

NanoMop SIGNED

Smart Cholesterol-Mopping Polymer Nanoparticles in Niemann-Pick Disease Type C

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 NanoMop project word cloud

Explore the words cloud of the NanoMop project. It provides you a very rough idea of what is the project "NanoMop" about.

family    therapies    treatment    therapeutic    urgently    create    class    intervention    international    fellowship    designed    decade    puts    broaden    training    cutting    bioavailability    cholesterol    suffers    health    genetic    carry    life    inter    niemann    considerable    decline    academic    charity    cyclodextrins    techniques    edge    detected    chemistry    sugars    career    excellent    sectoral    people    nanoparticles    smart    threatening    sequester    chemical    pharmacokinetics    disorder    researcher    networking    childhood    me    question    profile    rare    independent    biological    disease    overcome    limitations    progress    skillset    players    stakeholders    personally    poor    line    successfully    alzheimer    polymer    gained    mobility    capacity    bcds    caused    reaching    diversify    industrial    incidence    pursue    pick    cognitive    modification    completion    macromolecular    brain    competences    accumulation    nanomops    cds    answered    bcd    naturally    subsequent    complications    professionally    interdisciplinary    horizon2020    successful    position    recognised    occurring    area    significantly    internationally    npc   

Project "NanoMop" data sheet

The following table provides information about the project.

Coordinator
ISTANBUL TEKNIK UNIVERSITESI 

Organization address
address: AYAZAGA KAMPUSU
city: MASLAK ISTANBUL
postcode: 34469
website: www.itu.edu.tr

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Turkey [TR]
 Total cost 145˙845 €
 EC max contribution 145˙845 € (100%)
 Programme 1. H2020-EU.1.3.2. (Nurturing excellence by means of cross-border and cross-sector mobility)
 Code Call H2020-MSCA-IF-2017
 Funding Scheme MSCA-IF-EF-ST
 Starting year 2018
 Duration (year-month-day) from 2018-04-01   to  2020-03-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    ISTANBUL TEKNIK UNIVERSITESI TR (MASLAK ISTANBUL) coordinator 145˙845.00

Map

 Project objective

Niemann-Pick Disease Type C (NPC), also known as “childhood Alzheimer’s”, is a rare genetic disorder caused by the accumulation of cholesterol particularly in the brain with subsequent cognitive and mobility decline. In the EU NPC has an incidence of 1 per 100,000 people. Most cases are detected during childhood and progress to cause life-threatening complications by the second or third decade of life. Cyclodextrins (CDs), a family of naturally occurring sugars, have recently gained considerable attention as a potential therapeutic intervention in the treatment of the disease because of their capacity to sequester cholesterol. Although promising, the current treatment of NPC based on a chemical modification of bCD suffers from poor pharmacokinetics and bioavailability in the brain. In this project I propose a new interdisciplinary approach in which bCDs will be embedded into a novel class of smart polymer nanoparticles (NanoMops) that could overcome these limitations. The project addresses an important question that needs to be answered urgently and its successful completion will contribute to the treatment of the neglected disease in line with the Horizon2020 health goal of providing better and more effective therapies. My specific skillset in chemical modification of CDs puts me in a unique position to successfully carry out this project. This interdisciplinary proposal is designed to provide me with advanced training in macromolecular chemistry and in a range of cutting-edge biological techniques. The fellowship will significantly diversify my competences and broaden my profile – professionally and personally - enabling me to pursue a career as an internationally recognised independent researcher. The project will also create new important international and inter-sectoral partnerships with excellent academic and industrial players while reaching out to charity organisations, raising awareness and networking researchers and key stakeholders in the area of NPC.

 Publications

year authors and title journal last update
List of publications.
2019 Antonino Puglisi, Ece Bayir, Suna Timur, Yusuf Yagci
pH-Responsive Polymersome Microparticles as Smart Cyclodextrin-Releasing Agents
published pages: 4001-4007, ISSN: 1525-7797, DOI: 10.1021/acs.biomac.9b01083
Biomacromolecules 20/10 2019-10-30
2019 Antonino Puglisi, Yusuf Yagci
Cyclodextrin-Based Macromolecular Systems as Cholesterol-Mopping Therapeutic Agents in Niemann-Pick Disease Type C
published pages: 1800557, ISSN: 1022-1336, DOI: 10.1002/marc.201800557
Macromolecular Rapid Communications 40/1 2019-09-26

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "NANOMOP" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "NANOMOP" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.3.2.)

LiverMacRegenCircuit (2020)

Elucidating the role of macrophages in liver regeneration and tissue unit formation

Read More  

ROSETTA (2020)

Deciphering the Role of aberrant glycOSylation in the rEsponse to Targeted TherApies for breast cancer

Read More  

MY MITOCOMPLEX (2021)

Functional relevance of mitochondrial supercomplex assembly in myeloid cells

Read More